Bio-Rad Laboratories, Inc. Class A Common Stock vs Oatly Group AB - ADR — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $356.44 (market cap $9.43B), while Oatly Group AB - ADR trades at $12.93 (market cap $415.98M). The key difference: Bio-Rad Laboratories, Inc. Class A Common Stock is far larger — about 22.7× Oatly Group AB - ADR's market cap, and Bio-Rad Laboratories, Inc. Class A Common Stock is trading nearer its 52-week high, Oatly Group AB - ADR nearer its low. Which is the better fit depends on your goals.
| BIO | OTLY | |
|---|---|---|
Market Cap | $9.43B | $415.98M |
Sector | Health | Consumer Staples |
52-Week High | $356.25 | $18.54 |
52-Week Low | $241.71 | $8.03 |
Enterprise Value | $9.18B | $920.39M |
Trailing returns across standard periods
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, Icecreams, among others. It caters to Sweden, Germany, United Kingdom, Netherlands, North America, Finland, and other markets.
Read more on OTLY →